ATP Regeneration Patents: Mapping the Cofactor Recycling Field
Filings rose sharply from 2021 to 2024, climbing from 1 to 8 records a year (+700%) before the most recent, still-incomplete years. Annual filings were negligible before 2021, rose to a peak of 11 records in 2023, and grew from 1 record in 2021 to 8 in 2024 — a +700% increase over that span. 2025 and 2026 figures are still filling in as publications catch up to filing dates.
- 1THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV14
- 2GREENLIGHT BIOSCIENCES INC14
- 3NOVARTIS AG13
- 4CODEXIS INC12
- 5BOARD OF RGT THE UNIV OF TEXAS SYST5
See the full cofactor regeneration engineering — atp regeneration patent landscape analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions about ATP regeneration patents
What is ATP regeneration and why does it matter for biocatalysis patents?
ATP regeneration refers to enzymatic or engineered systems that continuously replenish adenosine triphosphate consumed during a biocatalytic or fermentation reaction, avoiding the cost of supplying stoichiometric ATP directly. It matters for patents because claims in this space typically bundle a regeneration module (an enzyme or pathway that regenerates ATP from ADP or AMP) with a separate primary reaction, such as phosphorylation or biosynthesis. This dataset shows the concept is most often claimed alongside microorganism or genetic-engineering elements (C12N) rather than as a standalone invention, which shapes how novelty gets argued during prosecution.
Who are the leading patent filers in cofactor regeneration engineering?
The ranked assignee list in this dataset covers 23 companies, with the top-ranked entity holding 14 records and a clear drop-off to 5 records by the fifth position. The leader is a university, and its strongest collaborative link is a co-assignee pairing with a specialty biocatalysis company, the single strongest pairing found in the data. Beyond the top few, filing activity thins into a long tail of organisations with only one or two records, which is typical of a field still in its growth phase rather than one dominated by a handful of large incumbents.
Is the ATP regeneration patent field still growing?
Yes, based on the years that can be treated as complete: filings grew from 1 record in 2021 to 8 in 2024, a +700% increase, with a peak of 11 records in 2023. Filings recorded for 2025 and 2026 appear lower only because publication typically lags filing by around 18 months, so those years are not yet fully populated. Read the recent uptick as a genuine expansion phase rather than a plateau, and expect the 2025-2026 counts to rise as more records publish.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Cofactor Regeneration Engineering — ATP Regeneration Patent Landscape covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.